Irvine Scientific Sales Company Inc Santa Ana, CA - 92705

Irvine Scientific Sales Company Inc is categorized under Blood Derivatives in Santa Ana, CA and active since 1987.

Irvine Scientific Sales Company Inc was established in 1987, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Blood Derivatives business, which does work in the B2B market, and is classified as a Blood Derivatives, under code number 325414 by the NAICS.

If you are seeking more information, feel free to contact Shusaku Sakata at the company’s headquarters by writing to 2511 Daimler St, Santa Ana, California CA 92705 or by phoning (949) 261-7800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Irvine Scientific Sales Company Inc
Contact Person: Shusaku Sakata
Address: 2511 Daimler St, Santa Ana, California 92705
Phone Number: (949) 261-7800
Website Address: irvinesci.com
Annual Revenue (USD): $20.000.000 to $49.9999.999
Founded: 1987
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Blood Derivatives
SIC Code: 2836
NAICS Code: 325414
Share This Business:

Irvine Scientific Sales Company Inc was started in 1987 to provide professional Blood Derivatives under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.

Feel free to contact Shusaku Sakata for inquiries that concern Irvine Scientific Sales Company Inc by calling the company number (949) 261-7800, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Irvine Scientific Sales Company Inc can be found at the coordinates 33.711127,-117.844596 as well as the street address 2511 Daimler St in Santa Ana, California 92705.

For its online presence, you may visit Irvine Scientific Sales Company Inc’s website at irvinesci.com and engage with its social media outlets through on Twitter and on Facebook.